Loss of DCC expression in astrocytomas: Relation to p53 abnormalities, cell kinetics, and survival

Journal of Clinical Pathology

Volumn 54, Issue 11, 2001, Pages 860-865

  Hara, A ^a   Saegusa, M ^a   Mikami, T ^a   Okayasu, I ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Astrocytoma; Cell kinetics; Deleted in colorectal carcinoma gene; p53

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN NERVE CELL; CANCER GRADING; CELL KINETICS; CELL SURVIVAL; CHILD; CONTROLLED STUDY; DELETED IN COLORECTAL CARCINOMA GENE; GENE; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LABELING INDEX; MAJOR CLINICAL STUDY; MITOSIS INDEX; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 0035168024     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.11.860     Document Type: Article

References (30)

1. Histopathology, classification, and grading of gliomas
2. MDM2 and p53 expression in gliomas: A multivariate survival analysis including proliferation markers and epidermal growth factor receptors
3. A tiger behind many doors: Multiple genetic pathways to malignant glioma
4. Identification of a chromosome 18q gene that is altered in colorectal cancers
5. The DCC gene product in cellular differentiation and colorectal tumorigenesis
6. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues
7. The DCC gene: Structural analysis and mutations in colorectal carcinomas
8. Loss of DCC gene expression during ovarian tumorigenesis: Relation to tumor differentiation and progression
9. bcl-2 and p53 oncoprotein during colorectal tumorigenesis
10. Apoptosis: Its significance in cancer and cancer therapy
11. Deleted in colorectal cancer (DCC) encodes a netrin receptor
12. Expression and glioma progression
13. cDCC (chicken homologue to a gene deleted in colorectal carcinoma) is an epithelial adhesion molecule expressed in the basal cells and involved in epithelial-mesenchymal interaction
14. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas
15. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers
16. Alterations in the deleted in colorectal carcinoma gene in human primary leukemia
17. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer
18. Frequent loss of heterozygosity at the DCC locus in gastric cancer
19. Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma
20. Expression of the tumor suppressor gene DCC in human gliomas
21. DCC expression is altered by multiple mechanisms in human brain tumors
22. The significance of the expression of tumor suppressor gene DCC in human gliomas
23. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labeling in brain tumors
24. Prognostic significance of p53 immunoreactivity in patients with glioma
25. Prognostic significance of Ki-67 labelling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
26. Prognostication of astrocytoma patient survival by Ki-67 (Mib-1), PCNA and S-phase fraction using archival paraffin embedded samples
27. Prognostic value of tumor associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: An analysis of 168 cases
28. bcl-2 and apoptosis in lymph node positive breast carcinomas
29. Apoptosis and mitosis as prognostic factors in pathologically staged N1 non-small cell lung cancer
30. Apoptotic index in ovarian carcinoma: Correlation with clinicopathologic factors and prognosis